Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma

Vascular endothelial growth factor (VEGF) serves an important role in new blood vessel formation or angiogenesis, which is a critical event in tumor growth and metastasis. Bevacizumab is a humanized monoclonal antibody against VEGF-A, whereas S-1 is a fluoropyrimidine antineoplastic agent that induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Itashiki, Yasutaka, Harada, Koji, Takenawa, Takanori, Ferdous, Tarannum, Ueyama, Yoshiya, Mishima, Katsuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371954/
https://www.ncbi.nlm.nih.gov/pubmed/34429770
http://dx.doi.org/10.3892/ol.2021.12991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371954/
https://www.ncbi.nlm.nih.gov/pubmed/34429770
http://dx.doi.org/10.3892/ol.2021.12991

Ejemplares similares